🔗 Permalink

Inventor profile of:

Marcel Bally

City:

Bowen Island

Country:

Canada

Published Applications:

Last publication date:

2018-11-29

Top Assignees for applications by Marcel Bally

The entities that hold a legal rights for patent applications filed by inventor Bally Marcel:

CELATOR PHARMACEUTICALS INC. 3 Ewing, NJ United States
CELATOR PHARMACEUTICALS, INC. 3 Princeton, NJ United States
BC CANCER AGENCY 3 Vancouver, BC Canada
BC Cancer Agency 2 Vancouver, Canada
THE UNIVERSITY OF BRITISH COLUMBIA 2 Vancouver, British Columbia, Canada
The University of British Columbia 2 Vancouver, Canada
University of British Columbia 2 Vancouver, British Columbia, Canada
UNIVERSITY HEALTH NETWORK 1 Toronto, ON Canada

Recent patent applications by Bally Marcel

Marcel Bally from Bowen Island, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-11-29

US20180338917A1

Human necessities

Compositions for delivery of drug combinations

#2 | 2018-08-09

US20180221279A1

Human necessities

MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES

#3 | 2016-04-28

US20160113871A1

Human necessities

Compositions for delivery of drug combinations

#4 | 2014-12-04

US20140356417A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#5 | 2013-09-12

US20130236534A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#6 | 2013-09-05

US20130230583A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#7 | 2013-09-05

US20130230582A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#8 | 2013-05-30

US20130136790A1

Human necessities

Liposomes with improved drug retention for treatment of cancer

#9 | 2012-09-20

US20120237591A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#10 | 2011-10-27

US20110262524A1

Human necessities

Liposomes with improved drug retention for treatment of cancer

#11 | 2011-07-07

US20110165225A1

Human necessities

Modified drugs for use in liposomal nanoparticles

#12 | 2010-12-14

US10417631

Compositions for delivery of drug combinations

#13 | 2009-01-29

US20090028931A1

Human necessities

Liposomal compositions for parenteral delivery of agents

#14 | 2008-11-20

US20080286350A1

Physics

Formulation of Multivalent Antibody Constructs and Use of Same for Cancer Therapy

#15 | 2008-09-04

US20080213183A1

Human necessities

Free or Liposomal Gemcitabine Alone or in Combination with Free or Liposomal Idarubicin

#16 | 2008-02-21

US20080044464A1

Human necessities

Liposome loading with metal ions

#17 | 2008-01-31

US20080026049A1

Human necessities

LIPOSOMAL COMPOSITIONS FOR PARENTERAL DELIVERY OF AGENTS

#18 | 2007-12-27

US20070298092A1

Human necessities

Compositions for delivery of drug combinations

#19 | 2007-07-03

US10264818

Liposome loading with metal ions

#20 | 2007-06-28

US20070148255A1

Human necessities

Compositions for delivery of drug combinations

#21 | 2007-02-08

US20070031480A1

Human necessities

Enhanced delivery of sphingolipids

#22 | 2006-10-26

US20060240090A1

Human necessities

Combination compositions of camptothecins and fluoropyrimidines

#23 | 2006-08-31

US20060193904A1

Human necessities

Liposome loading with metal ions

#24 | 2006-07-27

US20060165771A1

Human necessities

Compositions for delivery of drug combinations

#25 | 2005-03-17

US20050058697A1

Human necessities

Cell penetrating therapeutic agents

InventorID:

424238 ⎘